XML 140 R126.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidating Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net income $ 427,410 $ 863,330 $ 757,201
Changes in operating assets and liabilities and non-cash items included in net income 1,129,790 596,077 1,016,140
Net cash provided by operating activities 1,557,200 1,459,407 1,773,341
Cash flows from investing activities:      
Additions of property and equipment (707,998) (641,330) (617,597)
Acquisitions (96,469) (272,094) (310,394)
Proceeds from asset sales 19,715 8,791 62,258
(Purchases) proceeds from investment sales and other items (97,032) (373,096) (11,149)
Net cash used in investing activities (881,784) (1,277,729) (876,882)
Cash flows from financing activities:      
Long-term debt and related financing costs, net 619,698 (7,989) (438,007)
Other items (758,668) (156,990) (44,984)
Net cash used in financing activities (138,970) (164,979) (482,991)
Effect of exchange rate changes on cash (2,571) 2,293 (967)
Net increase in cash and cash equivalents 533,875 18,992 412,501
Cash and cash equivalents at beginning of the year 965,241 946,249 533,748
Cash and cash equivalents at end of the year 1,499,116 965,241 946,249
Consolidation, Eliminations      
Cash flows from operating activities:      
Net income (514,183) (982,776) (796,282)
Changes in operating assets and liabilities and non-cash items included in net income 514,183 982,776 796,282
DaVita HealthCare Partners Inc. | Reportable Legal Entities      
Cash flows from operating activities:      
Net income 269,732 723,114 633,446
Changes in operating assets and liabilities and non-cash items included in net income (146,531) (597,992) (443,071)
Net cash provided by operating activities 123,201 125,122 190,375
Cash flows from investing activities:      
Additions of property and equipment (115,269) (51,374) (55,252)
Proceeds from asset sales     60,650
(Purchases) proceeds from investment sales and other items (74,474) (333,803) (4,944)
Net cash used in investing activities (189,743) (385,177) 454
Cash flows from financing activities:      
Long-term debt and related financing costs, net 640,009 4,513 (421,739)
Intercompany borrowing 486,588 410,437 585,441
Other items (572,295) (58,207) 52,620
Net cash used in financing activities 554,302 356,743 216,322
Net increase in cash and cash equivalents 487,760 96,688 407,151
Cash and cash equivalents at beginning of the year 698,876 602,188 195,037
Cash and cash equivalents at end of the year 1,186,636 698,876 602,188
Guarantor Subsidiaries | Reportable Legal Entities      
Cash flows from operating activities:      
Net income 195,507 647,085 522,778
Changes in operating assets and liabilities and non-cash items included in net income 688,106 120,772 523,440
Net cash provided by operating activities 883,613 767,857 1,046,218
Cash flows from investing activities:      
Additions of property and equipment (319,695) (312,191) (337,919)
Acquisitions (76,983) (228,569) (156,830)
Proceeds from asset sales 19,715 8,791 1,608
(Purchases) proceeds from investment sales and other items (2,144) (316) (3,502)
Net cash used in investing activities (379,107) (532,285) (496,643)
Cash flows from financing activities:      
Long-term debt and related financing costs, net (11,953) (12,545) (11,061)
Intercompany borrowing (394,735) (282,461) (557,893)
Other items (66,382) (14,099) 4,726
Net cash used in financing activities (473,070) (309,105) (564,228)
Net increase in cash and cash equivalents 31,436 (73,533) (14,653)
Cash and cash equivalents at beginning of the year 77,921 151,454 166,107
Cash and cash equivalents at end of the year 109,357 77,921 151,454
Non-Guarantor Subsidiaries | Reportable Legal Entities      
Cash flows from operating activities:      
Net income 476,354 475,907 397,259
Changes in operating assets and liabilities and non-cash items included in net income 74,032 90,521 139,489
Net cash provided by operating activities 550,386 566,428 536,748
Cash flows from investing activities:      
Additions of property and equipment (273,034) (277,765) (224,426)
Acquisitions (19,486) (43,525) (153,564)
(Purchases) proceeds from investment sales and other items (20,414) (38,977) (2,703)
Net cash used in investing activities (312,934) (360,267) (380,693)
Cash flows from financing activities:      
Long-term debt and related financing costs, net (8,358) 43 (5,207)
Intercompany borrowing (91,853) (127,976) (27,548)
Other items (119,991) (84,684) (102,330)
Net cash used in financing activities (220,202) (212,617) (135,085)
Effect of exchange rate changes on cash (2,571) 2,293 (967)
Net increase in cash and cash equivalents 14,679 (4,163) 20,003
Cash and cash equivalents at beginning of the year 188,444 192,607 172,604
Cash and cash equivalents at end of the year $ 203,123 $ 188,444 $ 192,607